批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2023/09/08 |
SUPPL-25(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2020/12/10 |
SUPPL-22(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2019/03/27 |
SUPPL-20(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/04/17 |
SUPPL-16(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/03/05 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/07/24 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/07/24 |
SUPPL-9(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2001/05/31 |
SUPPL-8(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2000/06/14 |
SUPPL-6(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1999/11/23 |
SUPPL-7(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1999/04/21 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1998/04/30 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1996/03/08 |
SUPPL-3(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1994/09/29 |
SUPPL-2(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1994/02/16 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
1993/09/27 |
ORIG-1(原始申请) |
Approval |
Type 5 - New Formulation or New Manufacturer |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:DOBUTAMINE HYDROCHLORIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:EQ 50MG BASE/100ML 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020201 |
003 |
NDA |
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER |
DOBUTAMINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
EQ 50MG BASE/100ML |
Prescription |
Yes |
Yes |
AP |
1993/10/19
|
HOSPIRA |
020255 |
001 |
NDA |
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER |
DOBUTAMINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
EQ 50MG BASE/100ML |
Prescription |
Yes |
Yes |
AP |
1993/10/19
|
BAXTER HLTHCARE |
活性成分:DOBUTAMINE HYDROCHLORIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:EQ 100MG BASE/100ML 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020201 |
002 |
NDA |
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER |
DOBUTAMINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
EQ 100MG BASE/100ML |
Prescription |
Yes |
Yes |
AP |
1993/10/19
|
HOSPIRA |
020255 |
003 |
NDA |
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER |
DOBUTAMINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
EQ 100MG BASE/100ML |
Prescription |
Yes |
Yes |
AP |
1993/10/19
|
BAXTER HLTHCARE |
活性成分:DOBUTAMINE HYDROCHLORIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:EQ 200MG BASE/100ML 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020201 |
001 |
NDA |
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER |
DOBUTAMINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
EQ 200MG BASE/100ML |
Prescription |
Yes |
Yes |
AP |
1993/10/19
|
HOSPIRA |
020255 |
004 |
NDA |
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER |
DOBUTAMINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
EQ 200MG BASE/100ML |
Prescription |
Yes |
Yes |
AP |
1993/10/19
|
BAXTER HLTHCARE |
活性成分:DOBUTAMINE HYDROCHLORIDE 剂型/给药途径:INJECTABLE;INJECTION 规格:EQ 400MG BASE/100ML 治疗等效代码:AP
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
020255 |
005 |
NDA |
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER |
DOBUTAMINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
EQ 400MG BASE/100ML |
Prescription |
Yes |
Yes |
AP |
1993/10/19
|
BAXTER HLTHCARE |
020201 |
006 |
NDA |
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER |
DOBUTAMINE HYDROCHLORIDE |
INJECTABLE;INJECTION |
EQ 400MG BASE/100ML |
Prescription |
Yes |
Yes |
AP |
1994/07/07
|
HOSPIRA |